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The development of in vitro models to screen the effect of different concentrations, combinations 
and temporal sequences of morpho-regulatory factors on stem/progenitor cells is crucial to 
investigate and possibly recapitulate developmental processes with adult cells. Here, we designed 
and validated a microfluidic platform to (i) allow cellular condensation, (ii) culture 3D micromasses 
of human bone marrow-derived mesenchymal stromal cells (hBM-MSCs) under continuous 
flow perfusion, and (ii) deliver defined concentrations of morphogens to specific culture units. 
Condensation of hBM-MSCs was obtained within 3 hours, generating micromasses in uniform sizes 
(56.2 ± 3.9 μ m). As compared to traditional macromass pellet cultures, exposure to morphogens 
involved in the first phases of embryonic limb development (i.e. Wnt and FGF pathways) yielded 
more uniform cell response throughout the 3D structures of perfused micromasses (PMMs), and 
a 34-fold higher percentage of proliferating cells at day 7. The use of a logarithmic serial dilution 
generator allowed to identify an unexpected concentration of TGFβ 3 (0.1 ng/ml) permissive to hBM-
MSCs proliferation and inductive to chondrogenesis. This proof-of-principle study supports the 
described microfluidic system as a tool to investigate processes involved in mesenchymal progenitor 
cells differentiation, towards a ‘developmental engineering’ approach for skeletal tissue regeneration.
The in vitro recapitulation of key mechanisms and temporal sequence of events involved in embryonic 
organogenesis is increasingly being recognized of great importance in the field of Tissue Engineering1 
and more in general of regenerative medicine2,3. Several techniques for regenerating functional tissues 
have indeed found inspiration from developmental biology paradigms4, giving rise to the “so-called” 
field of developmental engineering5. In the context of skeletal tissues, this approach inspired the use 
of embryonic stem cells6 or human adult bone marrow-derived mesenchymal stem/stromal cells 
(hBM-MSCs)7–10 to recapitulate endochondral ossification processes through the early stages of limb 
development - namely cell condensation, undifferentiated proliferation of a mesenchymal cell popu-
lation and pre-chondrogenesis. During development, these steps are tightly regulated by the interplay 
of specific signaling pathways – namely, Wnt/β -catenin, FGF and TGFβ /BMP – defining complex and 
spatio-temporal gradients11. In detail, the proper activation of Wnt-canonical and FGF pathways initially 
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promotes the expansion of an undifferentiated pool of limb progenitors, which are subsequently capable 
to undergo chondrogenesis under the influence of members of the TGFβ /BMP superfamily12,13. Several 
studies have been carried out to elucidate the role of such pathways on hBM-MSCs fate, mainly using 
2D cell cultures and, only recently, more relevant pellet-based 3D models9,14–16. However, these 3D 
approaches still suffer from an overall heterogeneity in cell responses and a consistently low proliferation 
rate17. Their inadequacy could be ascribed to (i) the non-physiological forced initial cell condensation, 
(ii) the presence of necrotic cores within the aggregates due to the high number of cells (typically ranging 
from tens to hundred-thousand cells), (iii) the suboptimal culture conditions (i.e. the poor control over 
morphogen delivery), and (iv) the formation of undesired chemical gradients within the volume of the 
samples due to diffusion limitations. More effective and reliable in vitro models are thus required for 
investigating the response of mesenchymal cell systems to external morphoregulatory stimuli.
Microfluidics has been increasingly applied for generating high-throughput cell culture models, 
featuring unprecedented spatio-temporal control over microenvironmental conditions18. The establish-
ment of a highly-controlled continuous perfusion of culture medium within microchannels has indeed 
been demonstrated to maintain more uniform and controlled culture conditions than traditional static 
approaches, providing constant convective dilution of catabolites and stable supply of nutrients and mor-
phogenic factors18,19. Moreover, the ability to handle cells and fluids in precise configurations allows to 
tailor the microenvironment around cells, potentially achieving spatio-temporally controlled delivery of 
morphogen combinations20. Several microfluidic devices able to establish high-throughput 2D cell cul-
tures were developed, either within research laboratories21–24 or as commercial platforms (e.g. CellASICTM 
ONIX Platform, Millipore). However, the control over the third dimension still remains poorly explored 
due to the challenge of combining microfabrication techniques with the size-scale of 3D micro-tissues. 
Although promising results have been accomplished25–27, the ability to combine generation, culture under 
continuous perfusion, and analyses of micro-tissues within a single microfluidic device, has only been 
achieved by means of self-aggregating embryoid bodies (EBs), and in low-throughput platforms28,29.
In this study, we combine the features of microfluidic and 3D culture systems with the goal of devel-
oping a more physiological in vitro model of limb development. To this aim, we report an innovative 
microfluidic platform for the generation and culture of 3D micromasses of adult hBM-MSCs under 
continuous and controlled laminar flow perfusion. The device consists of two functional units: a 3D 
culture area and a serial dilution generator (SDG). The culture area was specifically designed to favor the 
condensation of tens of mesenchymal cells within fluidically-connected microchambers located in spa-
tially defined configurations, hence enabling the formation of micromasses with uniform size and shape. 
Two different SDG layouts were then implemented: the first characterized by a logarithmic configuration, 
allowing the investigation of soluble factors over a wide concentration range; the second featuring a 
linear layout for finer tunings within narrower concentration windows.
The developed microfluidic platform allowed us to achieve a more uniform and repeatable response of 
3D perfused micromasses (PMMs) to specific morphogens involved in limb bud development (i.e. TGFβ , 
Wnt and FGF pathways), in comparison with traditional macroscale pellet culture models14. Finally, the 
effect of concentration patterns of a key morphoregulatory factor (TGFβ 3) on hBM-MSCs 3D prolifera-
tion and differentiation was preliminarily investigated in a high-throughput fashion. This confirmed the 
suitability of the platform to be further exploited as an in vitro model to sequentially guide hBM-MSCs 
towards the primordial steps of the endochondral route.
Results
Microfluidic platform for generating and culturing 3D perfused micromasses. Two micro-
fluidic platforms were designed for the generation and culture of cellular micromasses under spatially 
controlled chemical microenvironments (Fig. 1a). Two SDG layouts were designed based on a resistive 
flow scheme consisting of microfluidic networks30 able to generate linear (100%, 80%, 60%, 40%, 20%, 
0%) or logarithmic (100%, 10%, 1%, 0.1%, 0%) concentration profiles of soluble factors. The microfluidic 
networks were composed of thin fluidic-resistance microchannels (70 μ m wide and 70 μ m high), whose 
lengths were dimensioned to allow diffusive mixing of soluble factors, while ensuring equal flow rates 
among the outlets. To this purpose, flow rates up to 12 μ l/h were considered to mix chemical species 
characterized by diffusion coefficients as low as D ~ 10-6 cm2 sec–1. Both SDGs were rather compact, occu-
pying a footprint of about 2.5 cm2. Due to the different design scheme, the required ratio between flow 
rates at input ports (A1 and B1 in Fig. 1a) were 1:1 and 1:3.5 for linear and logarithmic configurations, 
respectively.
Serial dilutions are independently delivered to downstream culture units. Each unit (Fig. 1a, C1-C6) 
comprises 10 cubic culture chambers (side of 150 μ m) and it is integrated with a secondary channel (Fig. 1a, 
D1-D6). The chambers were dimensioned to culture 3D PMMs while ensuring enough space for their 
early expansion. Two secondary inlets (Fig. 1a, A2-B2) were also included in the layouts to facilitate the 
medium change operations, defining a by-pass for the device.
Characterization of serial dilution generators. Linear and logarithmic SDGs were experimentally 
characterized in terms of distribution of flow rates and generation of designed chemical concentration 
patterns at the outlets.
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Flow rates were rather uniformly distributed among the outlets in both SDG configurations. In the 
linear version, a total inflow of 24 μ l/h was used (12 μ l/h at each input port) and a maximum variation 
of 3% from the expected value (4 μ l/h) was detected. Similarly, in the logarithmic configuration, a total 
inflow of 45 μ l/h was imposed (10 μ l/h at inlet A1 and 35 μ l/h at inlet B1), resulting in a maximum var-
iation of 5% from the expected outflow value (9 μ l/h).
The actual pattern profile of the chemical concentration was then assessed using two different read-
out approaches. For the linear SDG, two dye solutions were perfused at 10 μ l/h and allowed to mix 
within the device, as exemplified in Fig. 2a. The six dilutions collected from the outlets matched with 
the expected linear distribution (R2 = 0.9891) (Fig. 2b). For the logarithmic SDG a more sensitive read-
out was required, being the output dilutions widespread over four orders of magnitude. Bovine serum 
albumin (BSA, Sigma, Buchs SG, Switzerland) protein was dissolved in distilled water (dH2O) and used 
for quantitative assessments. The BSA concentration of the five dilutions collected from the output ports 
were measured to range over four orders of magnitude (1, 0.1, 0.01, 0.001 and 0, as negative control), 
matching the expected logarithmic distribution (R2 = 0.9908) (Fig. 2c).
Perfused micromasses generation within the microfluidic device. Live phase contrast images 
of hBM-MSCs, initially inoculated into the microchambers, documented a progressive cell condensation 
(Fig. 3a). The condensation process was completed in about three hours from seeding, determining the 
formation of roughly spherical micromasses (Fig. 3b). To avoid culture medium evaporation during the 
cell condensation phase, a mild perfusion (500 nl/h) was maintained throughout this timeframe. At this 
time point, the micromasses featured a diameter of 56.2 ± 3.9 μ m, occupying around 3% of the cham-
ber volume, and consisting of 77 ± 15 cells, as predicted by experimental correlation based on a model 
described in Supplementary Information (SI1).
Early formation of adhesion contacts among cells was also assessed. Fig. 3c shows that neural cadherin 
(N-cadherin) started to be expressed within 3 hours after seeding, suggesting the initiation of cell-cell 
Figure 1. Microfluidic device layouts (a) and fabrication process (b) The chip layouts consist of a serial 
dilution generator – either featuring a linear or a logarithmic configuration - and a 3D culture area (a) 
Dilutions of chemicals can be generated from two main inlets (A1-B1) and delivered to downstream culture 
units (C1-C6); furthermore, each unit is provided with a secondary channel (D1-D6). Two additional inlets 
(A2-B2) facilitate the medium change operations, defining a by-pass for the device. The final device is 
fabricated with PDMS following standard soft-lithography techniques. First, the PDMS microstructured layer 
is bonded facing up to a PDMS top layer; then the device is bonded to a glass cover slide (b).
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contacts. Noteworthy, the remodeling of actin cytoskeleton network as well as the expression of vinculin 
were also detected (Fig. 3d) within the interconnecting cells.
3D cell proliferation: comparison between macroscale and microfluidic models. Cell prolifer-
ation within PMMs was assessed over a period of 7 days17 in culture upon TGFβ 3 (Transforming Growth 
Factor β 3) conditioning, and it was compared to traditional 3D macroscale cultures (macromass pellets). 
In particular, two parameters were monitored throughout the culture: (i) the total number of proliferative 
(i.e. Edu positive, Edu+) cells within samples, and (ii) the variations of aggregate dimensions.
Figure 4a,b and Fig. 4c,d show representative images of the Edu incorporation assay for both macro- 
and micro-aggregates, respectively. The macromass pellets exhibited up to 0.64 ± 0.34% Edu+ cells at day 
7 (Fig. 4e), whereas a statistically significant higher number (i.e., 21.64 ± 11.13% at day 7, Fig. 4e) was 
found within PMMs. Noteworthy, Edu+ cells were mostly found along the contour of macromass pellets 
(Fig. 4a,b), while proliferative cells were uniformly distributed within the PMM volume (Fig. 4c,d). The 
specificity of the Edu incorporation was confirmed by analyzing colchicine-treated samples, where no 
proliferative cells were detected (see Supplementary Information, Fig. SI5d). Consistently, macromass 
pellets exhibited a statistically significant reduction in diameter (− 15.3% ± 3.9%) from day 0 to day 7 
(Fig. 4f), associated with a drop in the DNA content (see SI2). An overtime increase in dimensions was 
conversely measured for the PMMs (+ 4.7% ± 1.8%) during the same timeframe (Fig. 4g), correlated with 
an increase in cell number (see Supplementary Information, Fig. SI1).
Effect of Wnt3a, FGF2 and TGFβ3 on perfused micromasses proliferation. The effect of differ-
ent morphogen combinations on hBM-MSCs PMMs proliferation was assessed within the microfluidic 
platform.
Preliminary experiments were carried out on 2D cultures to identify a dose-response curve for dif-
ferent combinations and concentrations of morphogens on hBM-MSCs proliferation, yielding to 2D 
dose response curves. Based on the obtained results (Fig. SI3 and SI4), the most promising conditions 
in terms of cell proliferation were selected and translated within the proposed microfluidic model. In 
details, PMMs were cultured for 3 days in serum free medium (SFM) conditioned either with a combi-
nation of 20 ng/ml rhWnt3a (wingless-type MMTV integration site family member3a; R&D) and 5 ng/
ml FGF2 (Fibroblast Growth Factor2) or with 1 ng/ml of TGFβ 3 (Transforming Growth Factor β 3). 
A control condition (named vehicle) was also established by culturing PMMs in SFM only. After 3 
days in culture, the vehicle condition exhibited slight increases in both cell number and microaggre-
gate diameter, comparable with those obtained in the TGFβ 3-treated group. However, the percentage 
increase of cell number with respect to day 0 was significantly higher when micromasses were perfused 
with Wnt3a+ FGF2 (66.4% ± 15.1%) as compared to both TGFβ 3 (11.1% ± 4.0%) and vehicle conditions 
(3.7% ± 6.4%) (Fig. 5a). Similarly, a statistically significant increase in micromasses diameter was also 
detected in the Wnt3a+ FGF2-treated group (36.5% ± 12.8%) as compared to both TGFβ 3 (4.7% ± 1.8%) 
and vehicle conditions (1.6% ± 1.7%) (Fig. 5b). These results confirmed the outcomes of the prelimi-
nary 2D experiments, underlining the preponderant role of Wnt3a and FGF2 in the enhancement of 
hBM-MSCs proliferation.
Figure 2. Characterization of serial dilution generators (SDGs). The linear device was perfused with 
dye solutions and, after reaching the steady state, a linear color pattern was visible in the SDG (a) The 
quantitative measurement of the emission wavelengths of the 6-outlet solutions (normalized for the λ max) 
resulted in a linear trend (n = 3) (b) The logarithmic device was characterized by perfusing 20 mg/ml 
BSA solution and measuring the concentration achieved after mixing within the SDG by means of a BCA 
assay. The quantitative measurement of the 5-outlet solutions resulted in a logarithmic trend, matching the 
expected concentrations (n = 3) (c).
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Type II collagen expression was then assessed for the three tested conditions, as to investigate the 
role of selected morphogens in the early expression of a chondrogenic marker. Results depicted in 
Fig. 5 show that type II collagen was only detected in the TGFβ 3-treated group (Fig. 5e). Conversely, 
no collagen II was expressed either in the (Wnt3a+ FGF2)-stimulated group (Fig. 5d) or in the control 
condition (Fig. 5c), confirming the different role of the tested morphogens in conditioning hBM-MSCs.
Logarithmic screening of the TGFβ3 effect on perfused micromasses proliferation and dif-
ferentiation. The microfluidic platform was finally exploited as a high-throughput tool for screening 
the concentration-dependent effect of morphogens on PMMs. By means of the logarithmic SDG device, 
four orders of magnitude of TGFβ 3 concentrations were spanned (0.1, 1, 10 and 100 ng/ml, using 0 ng/
ml as negative control condition) (Fig. 6). The highest concentration of TGFβ 3 (100 ng/ml) led to micro-
masses disaggregation (Fig. 6a,b), with no detectable cell proliferation or chondrogenesis (Fig. 6c,d). At 
the concentrations commonly used for in vitro chondrogenic differentiation protocols14,31, cells did not 
proliferate but consistently deposited type II collagen. Interestingly, the lowest TGFβ 3 concentration 
(0.1 ng/ml) showed to be able to maintain proliferating cells over seven days while inducing chondro-
genic differentiation, as assessed by type II collagen deposition.
Discussion
The recapitulation of the events occurring during limb development using adult stem/progenitor cells is 
currently being widely pursued in order to develop in vitro and in vivo strategies for skeletal tissue regen-
eration, according to the principles of “developmental engineering”8. In this regard, the reproducible 
Figure 3. PMMs condensation. Time lapse phase contrast images of hBM-MSCs, initially filling a 
microchamber. Cells started to aggregate within tens of minutes while reaching a complete non-externally 
induced condensation after 3 hours from the seeding (a) Resulting PMMs were cultured within the chambers 
initially occupying about 3% of the volume (b) Immunofluorescence images showed the expression of 
adhesion proteins. The achievement of a full hBM-MSCs condensation is confirmed after 3 hours from 
seeding by N-cadherin expression, a cell adhesion molecule involved in the initiation of cell condensation 
(c) Moreover, the presence of an actin cytoskeleton network was showed, tightly connecting the cells after 
3 hours from seeding (d).
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instruction of clinically-relevant cell sources (e.g. hBM-MSCs) toward the endochondral route requires 
a deep understanding over their response to key morphoregulatory stimuli in 3D models9. In this study, 
we developed a platform for in vitro generation and culture of 3D mesenchymal cell micromasses under 
continuous and controlled perfusion, enabling a high-throughput exposure to exogenous factors and 
live cell imaging. We demonstrated that hBM-MSCs can form 3D aggregates upon injection into culture 
microchambers, and respond more uniformly and efficiently to key morphogens when perfused into the 
system as compared to traditional static approaches. The work thus provides a proof-of-principle of the 
microfluidic platform potentialities as a high-throughput tool to screen the effect of key morphogens in 
a 3D spatiotemporally-controlled fashion.
To date, several strategies have been developed to induce the condensation of cell micromasses by 
means of static approaches (i.e. hanging-drop techniques, microwells)32–36, aiming at demonstrating the 
benefits of the scale reduction of 3D models. Although effective, these approaches still rely on static 
and manual culture systems, unable to efficiently investigate 3D cell responses in an automated manner. 
Alternatively, pre-formed micromasses have been injected within microfluidic platforms for the subse-
quent culture under controlled conditions25–27. However, only few available devices can integrate both 
functionalities, and they mainly rely on the intrinsic ability of embryonic cells to spontaneously form 
EBs28,29. Attempts have been recently made to generate microaggregates within microfluidic platforms 
starting from adult cell sources; nonetheless, they were mostly based on complex multiple-layer designs 
in which cell condensation was induced through the formation of vortices and rotational flows within 
microchambers37,38.
We developed an innovative microfluidic platform consisting of a single-layered device integrating 
independent culture units, each featuring 10 cubic chambers (thus potentially useful for studying the 
effect of paracrine factors), serially connected to a fluidic network designed to precisely deliver given con-
centrations of morphogens. Such powerful microfluidic tool integrates for the first time the capabilities 
to (i) uniformly generate 3D cell micromasses into defined spatial configurations and (ii) culture them 
under continuous laminar flow perfusion of specific morphogens concentrations. In particular, the plat-
form allowed obtaining condensation of tens of hBM-MSCs (77 ± 15) within each culture microchamber 
into spherical micromasses, without the need of any rotational flow or external induction. Through the 
use of a computational fluid-dynamics model, the shear stress experienced by hBM-MSCs in this phase 
was indeed estimated to be negligible to cell condensation39 (see Supplementary Information FigSI6). The 
condensation phenomenon, hence classified as non-externally induced, was possibly due to (i) the low 
adhesiveness of the PDMS substrate, (ii) the geometry and size of the microwells, and (iii) the relative 
ratio between the cell number and well size, yielding a high cell density in a confined small volume. The 
non-externally induced condensation of hBM-MSCs is an important achievement in comparison with 
the traditional scaffold-free systems involving 3D mesenchymal cell cultures, which are mainly based on 
macromass pellets obtained by centrifugation14,17. This initial forced centrifugation step indeed leads to 
Figure 4. Comparison between macroscale pellet and microfluidic models in terms of 3D cell proliferation 
potential. Representative Edu immunofluorescence images showed a higher and more homogeneously 
spatially distributed number of Edu-expressing cells within the PMMs (c,d) than within the pellet sections 
(a,b) as confirmed by a statistically significant difference in the %Edu+ cells for both the considered time 
points (e) The assessment of the aggregates diameter over 7 days showed opposite trends: a statistically 
significant decrease for macroscale pellets (f) while a slight increase for the microfluidic model (g) (n = 3. 
For the microscale two donors were considered twice.*p < 0.05. **p < 0.01).
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the establishment of too tight cell-cell and cell-ECM interactions, high variability in the time required to 
form 3D aggregates (24÷ 72 hours), and non-uniformly shaped tissues40. Conversely, the proposed plat-
form was permissive of an initial condensation of hBM-MSCs within 3 hours, generating micromasses 
featuring rather uniform sizes (56.2 ± 3.9 μ m). The early organization of actin microfilaments in the cells 
coupled with a rather uniform expression of vinculin and N-cadherin suggests an effective and functional 
interconnection among cells within the PMMs. However, further investigations should be performed 
to (i) characterize the biological pathways involved in hBM-MSCs aggregation, (ii) study the temporal 
maturation of such complex network, and (iii) compare the cell condensation dynamics in the proposed 
model with those occurring during limb development.
The platform was further exploited to culture generated micromasses under controlled perfusion 
aiming at investigating the uniformity of their response to external morphogens stimuli. As compared 
to traditional macropellets models, which mainly suffered from an overall heterogeneity in cell responses 
correlated with the presence of necrotic cores17,41, PMMs exhibited a 33.8-fold higher percentage of 
Edu+ cells, homogeneously spread throughout the whole volume. These observations confirmed the 
potentiality of the model in replicating the 3D expansion step occurring during the early stages of limb 
Figure 5. Effect of Wnt3a, FGF2 and TGFβ 3 on hBM-MSCs microaggregates behavior. After 3 days 
in culture, both the percentage increase of cell number (a) and diameter (b) with respect to day 0 was 
significantly higher when microaggregates were conditioned with Wnt3a +  FGF2 compared to TGFβ 3 
condition (**p < 0.01; ***p < 0.001). A negative control was also performed (named vehicle), culturing 
microaggregates in SFM without morphogens, leading during the 3 days culture to slight increases in cell 
number and microaggregate diameter, comparable with those obtained in the TGFβ 3 group. Collagen II 
expression was then investigated for the three conditions. Results showed an expression of Collagen II 
only in the TGFβ 3-treated group, possibly indicating its role in triggering a differentiation towards the 
chondrogenic lineage (e) Conversely, no Collagen II was detected neither in the (Wnt3a + FGF2)-stimulated 
group (d) or in the control condition (c).
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development11, thus overcoming one of the main limitations of macroscale models, i.e. an overall drop 
in cell number regardless of the culture conditions17 (see supplementary information, fig. SI2).
Furthermore, a pre-chondrogenic expansion similar to that occurring in the limb bud was achieved. 
Indeed, through a combination of Wnt3a and FGF2, an increase in cell number of 66.4 ± 15.1% was 
observed in the PMMs from day 0 to day 3, whereas no expression of collagen type-II was detected. 
Conversely, the perfusion of TGFβ 3-based medium induced an earlier onset of TGFβ -mediated chon-
drogenesis as compared to macroscale models42, as exemplified by the expression of collagen type-II 
already after 3 days in culture.
Finally, the use of the serial dilution generator unit allowed to screen the concentration-dependent 
effect of a key morphoregulatory factor (i.e. TGFβ 3) on the 3D hBM-MSCs model. The obtained 
proof-of-principle results underline the efficacy of the presented model to detect different cell responses 
in the presence of different morphogen concentrations, spanning over four orders of magnitude. 
Interestingly, the lowest concentration tested (100 pg/ml) was sufficient to trigger specific cellular 
responses (i.e. chondrogenic specification and cellular proliferation), which cannot be detected either at 
Figure 6. Logarithmic concentration screening over the effect of TGFβ 3 on PMMs proliferation and 
differentiation. hBM-MSCs were cultured for 7 days under continuous perfusion of chondrogenic medium 
exhibiting a concentration gradient of TGFβ 3 spanning over four order of magnitude (0, 0.1, 1, 10 and 
100 ng/ml). Phase contrast images at day0 (a) and day7 (b) showed the toxic effect of the highest factor 
concentration, leading at micromasses disaggregation at the end of the culture period. Cell proliferation (c) 
and chondrogenesis (d) were investigated after 7 days in culture by staining PMMs for Ki67 and Collagen II 
expression, underling TGFβ 3 concentration-dependent cell responses.
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the macroscale or in 2D models, without delivering at least hundred times higher concentrations of the 
morphogen. Our findings indicate the potentiality of the presented microfluidic system to investigate the 
effect of key morphogens, applied in a controlled and high-throughput fashion in different sequences, 
combinations and concentration ranges, on early stages of 3D chondrogenesis by hBM-MSCs. Moreover, 
the presence of secondary inlets within the platform will allow the integration of an automated control 
over the delivery of morphogens to further investigate time-dependent effects of such key signaling 
pathways.
In conclusion, our study suggests a possible use of such microfluidic device as in vitro platform 
for “development-inspired” investigations. After assessing the portability of the presented technology 
to different cell sources (e.g. mesenchymal limb progenitors), we envision the possibility to extend the 
applicability of this platform to different biological models, where initial cell condensation and the onset 
of a 3D structure is expected to mediate a physiological response to exogenous signals. Once clarified 
these critical points, the proposed microfluidic platform may find further applications in the field of 
developmental biology - e.g. as an in vitro limb bud model - as well as in the pharmaceutical industry 
for screening compounds intended to induce regeneration of mesenchymal tissues.
Methods
All reagents were purchased from Gibco (Life Technologies, Zug, Switzerland) if not otherwise indicated.
Ethics statement. Primary human cells were obtained from 3 healthy donors (24-44 years old, 
mean age: 34) during routine orthopedic surgical procedures, following informed patient consent and in 
accordance with the approved guidelines. The experimental protocol was approved by the local ethical 
committee (Ethische Kommission Beider Basel, EKBB, Ref. 78/07).
Microfluidic platform fabrication. The microfluidic layouts (Fig. 1a) were designed by means of a 
CAD software (AutoCAD, Autodesk Inc.) and the corresponding master molds were realized through 
photolithography techniques43. A thin microfluidic layer (thickness 1 mm) was obtained by replica mold-
ing of polydimethylsiloxane (PDMS; Sylgard® Dow Corning, Michigan, USA). Briefly, liquid PDMS was 
cast on the mold in ratio 10:1 w/w (pre-polymer to curing agent), degassed and cured at 80 °C for 3 h. The 
obtained PDMS microstructured layer was permanently bonded facing up to a flat PDMS slab (thickness 
5 mm), upon 1 min of air plasma treatment (Harrick Plasma, NY, USA), thus closing the channels. Input 
and output ports were obtained through a 0.5 mm biopsy puncher (Harris Uni-CoreTM). The chip was 
finally permanently bonded to a glass coverslide (diameter 50 mm, thickness 150 μ m; VWR International 
Inc., PA, USA) upon an additional 1 min exposure to air plasma (Fig. 1b). External connections were 
realized through tygon tubings (ID = 0,02”; Qosina, NY, USA) and stainless steel couplers (23 gauge; 
Instech Laboratories Inc., PA, USA).
Characterization of the serial dilution generator. Linear and logarithmic SDGs were character-
ized in terms of flow rate distribution to verify the correct partitioning of the inflow among culture units. 
Tygon tubings were connected at the output ports and an overall flow rate of 24 μ l/h for the linear SDG 
and 45 μ l/h for the logarithmic one was imposed through the inlets. The outflow from each outlet was 
quantified by measuring the travel length of each meniscus within the tubing.
Quantitative evaluations of chemical patterns generated by the SDGs were performed44. For the linear 
configuration, two dye solutions were pumped through the main inlets at a flow rate of 10 μ l/h. After 
the achievement of a steady state condition, samples of 20 μ l (n = 3) were collected from each outlet. 
A spectrophotometer (NanoDrop 2000c, Thermo Scientific, Wilmington, USA) was used to detect the 
average emission wavelength for each condition. For the logarithmic SDG, a solution of 20 mg/ml BSA 
in dH2O was pumped into the right inlet (A1) at a flow rate of 10 μ l/h while dH2O was pumped into the 
left one (B1) at 35 μ l/h. After the achievement of a steady state condition, samples of protein dilutions 
were collected from each outlet (n = 3) and the BSA concentration was measured by means of a BCA 
Protein Assay kit (Pierce, Thermo Fisher Scientific, Reinach, Switzerland), following the manufacturer’s 
indications.
Cell isolation and expansion. Human mesenchymal stromal cells (hBM-MSCs) cultures were estab-
lished as previously described45. hBM-MSCs were expanded in alpha-MEM containing 10% fetal bovine 
serum (FBS), 4.5 mg/ml D-glucose, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 100 mM 
HEPES buffer, 100 Ul/ml penicillin, 100 μ g/ml streptomycin, and 0.29 mg/ml L-glutamate, further sup-
plemented with 5 ng/ml FGF2 (Fibroblast Growth Factor2; R&D Systems, Minneapolis, MN, USA). 
Medium was changed twice a week and hBM-MSCs were used between P1 and P3 for the experiments.
Macroscale pellet cultures. Macromass pellets were established and used as control. In details, ali-
quots of 2.5 × 105 cells/0.25 ml hBM-MSC were centrifuged at 1,100 rpm for 5 min to form pellets. Pellets 
were cultured under static conditions up to one week in SFM, consisting of DMEM with 1 mM sodium 
pyruvate, 100 mM HEPES buffer, 100 UI/ml penicillin, 100 μ g/ml streptomycin, 0.29 mg/ml L-glutamate, 
0.1 mM ascorbic acid 2-phospate (Sigma), ITS+ 1 (Sigma, 10 μ g/ml insulin, 5.5 μ g/ml transferrin, 5 ng/
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ml selenium), 5 μ g/ml human serum albumin, and 4.7 μ g/ml linoleic acid further enriched with 1 ng/ml 
TGFβ 3 (Transforming Growth Factor β 3) and medium was changed twice a week.
Perfused micromasses generation and culture within the microfluidic device. Before cell seed-
ing, microfluidic devices were sterilized by autoclaving (121°C, 20 min, wet cycle) and dried overnight 
at 80°C to recover PDMS hydrophobicity and minimize cell adhesion in the chambers during seeding. 
Devices were then submerged in sterile PBS and degassed46. Subsequently, SFM was perfused through 
the main inlets of the device (Fig. 1a, A1 and B1).
After expansion hBM-MSCs were detached, diluted to the concentration of 107 cells/mL in SFM, 
and seeded into the culture units by perfusing 0.1 μ l/min of cell suspension from all outlets (C1-C6), 
while maintaining an opposite mild medium flow (0.5 μ l/min) from each inlet (A1-B1). The secondary 
channels (D1-D6) were used as waste lines both during the seeding procedure, to avoid cell clogging in 
the upstream channels, and during the initial cell condensation phase, to reduce the shear stress experi-
enced by seeded hBM-MSCs. Secondary channels were instead clamped during the culture period. Once 
the culture chambers were filled with hBM-MSCs, a continuous flow rate of 5 μ l/h per line was applied 
and maintained throughout the entire experiment, while the microfluidic platform was incubated under 
standard culture conditions (T = 37°C, 5% CO2 and humidified atmosphere). Phase contrast images of 
hBM-MSCs seeded into the microchambers were acquired every 15 minutes during the first 4 hours of 
culture to monitor the micromasses condensation.
The generated micromasses were cultured up to seven days under continuous perfusion of different 
conditioning media. In details, SFM was enriched either with 1 ng/ml TGFβ 3 (Transforming Growth 
Factor β 3) or with a combination of 20 ng/ml rhWnt3a (wingless-type MMTV integration site family 
member3a; R&D) and 5 ng/ml FGF2 (Fibroblast Growth Factor2).
3D cell proliferation assays. SFM enriched with 10 μ M Edu was either added to the macropellet 
cultures or continuously perfused within the microfluidic device at specific time points (day 2 and 6). 
Different incubation times with Edu were tested (see Supplementary Information, Fig. SI5a-c) and an 
exposure time of 24 hours was selected as the one giving an adequate temporal window over the cell 
cycle17. The quantification of Edu+ cells was performed via immunofluorescence staining upon incor-
poration of Edu, as described in the Immunofluorescence analyses sub-section. Negative controls were 
obtained by treating samples with colchicine (100 ng/ml; Invitrogen, Life Technologies) from day 0 of 
culture, to inhibit cell division (see Supplementary Information, Fig. SI5d). Further negative controls 
were established by preventing cells from Edu exposure (see Supplementary Information, Fig. SI5e).
PMMs live phase contrast images were acquired using an Olympus BX-61 (Olympus, Tokyo, Japan) 
and the average diameters were evaluated by means of the ImageJ software (http://imagej.nih.gov). 
The corresponding cell number was calculated in correlation with the micromasses diameter applying 
an algorithm developed by Martin et al.47 and validated for our specific samples (see Supplementary 
Information). Concerning macropellets, the diameter was directly measured, while the cell number 
quantification was carried out by means of a standard CyQUANT® cell proliferation assay kit (Molecular 
Probes, Life Technologies).
Logarithmic screening over the effect of TGFβ3 on micromasses. Exploiting the SDG unit, 
hBM-MSCs micromasses were cultured under continuous perfusion of chondrogenic medium (SFM 
enriched with of 10-7 M dexamethasone), while serial dilutions of TGFβ 3 were established throughout 
the logarithmic SDG configuration. After 7 days in culture, PMMs were analyzed both in terms of cell 
proliferation and chondrogenic differentiation, by immunofluorescence for Ki67 and collagen II, respec-
tively, as described in the specific sub-section.
Immunofluorescence analyses. At specific time points, immunofluorescence analyses were per-
formed using Dapi as counterstaining. Microaggregates were fixed by perfusing 4% paraformaldehyde for 
20 min and immunofluorescence stainings were obtained by sequentially perfusing the required solutions 
directly within the device at constant flow rate (1 μ l/min). Briefly, a solution of 3% goat serum and 0.5% 
Tween20 (Sigma) in PBS was perfused for 45 min to permeabilize cells and to block nonspecific bind-
ings. Expression of vinculin and N-cadherin were detected by perfusing 10 μ g/ml Mouse Anti-Vinculin 
(BD, Allschwil, Switzerland) and Mouse Anti-N cadherin (R&D) for 1 hour. Actin cytoskeleton was 
stained by further perfusing a FITC-conjugated phalloidin solution (BD) for 45 min. Cell proliferation 
and expression of collagen II within microaggregates was also evaluated by perfusing 10 μ g/ml of Rabbit 
Anti-Ki67 and 10 μ g/ml of Mouse Anti-Collagen II (R&D) solutions for 1 hour. Finally, microaggregates 
were perfused with specific secondary antibodies (Goat Anti-Mouse IgG1 Alexa Fluor 546-conjugated 
for vinculin, Goat Anti-Mouse IgG1 Alexa Fluor 488-conjugated for N-cadherin and collagen II and 
Goat Anti-Rabbit IgG for Ki67) for 45 min.
Immunofluorescence for Edu staining was performed on both Edu-treated PMMs and sections 
of macropellets by using Alexa Fluor 555-conjugated Click-iT Edu Assay kit (Molecular Probe, Life 
Technologies), according to the manufacturer’s indications. The micromass staining was performed by 
sequentially perfusing the required solutions directly within the microfluidic platform, as described 
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above. Macropellets instead were fixed in 4% paraformaldehyde overnight, dehydrated, and embedded 
in paraffin. Five micrometers thick sections were then cut by means of a Microm HM400 microtome and 
the Edu staining was obtained following a standard protocol17.
Confocal images of immunofluorescence micromasses were acquired directly within the devices by 
means of a Nikon A1R Nala Confocal microscope (Nikon, Tokyo, Japan), while immunofluorescence 
sections of macropellets were analyzed by means of an Olympus BX-61 microscope17. The 3D percentage 
of Edu+ cells over the total number of cells was calculated through ImageJ software (NIH).
Statistical analysis. Data are expressed as mean ± standard deviation, and statistical analyses (t-test 
and one-way ANOVA, with a 99% confidence level, Bonferroni post-hoc test) were performed using 
GraphPad Prism v5.00 (GraphPad Software, San Diego, CA).
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